MVA-BN (Bavarian Nordic)

N/A

Report date: 2025/03/26 09:16:33

Base Information

Drug NameMVA-BN (Bavarian Nordic)
Drug Alias NameModified vaccinia Ankara virus (Bavarian Nordic)ImvanexImvamuneMVA-BN
ClassificationVaccines > Development/production technology > Live attenuated vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsDermatitis, AtopicRhinitis, Allergic, SeasonalSmallpox +[5
Global Approved IndicationsSmallpox
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2013/07/31
Country/TerritoryUnited StatesUgandaPuerto Rico +[7
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesBavarian Nordic A/S
China Registration ClassN/A

Develop Information

Active CompaniesBavarian Nordic A/S
Active IndicationsSmallpoxMonkeypox
Inactive IndicationsDermatitis, AtopicRhinitis, Allergic, SeasonalHIV Infections

Other Information

ATC CodeJ07BX
Related LinksWikipedia